MOH

NEUTRAL

$145.88

P/E

17.09

PEG

FCF Yield

Rev Growth YoY

+1175.0% YoY

Gross Margin

1307.0%

Health Score

5/10

D/E Ratio

0.98

Confidence

LOW


Business Snapshot

The ticker and exchange identifiers are absent from this data payload, making it impossible to describe the company's specific business activities or market positioning with confidence. Based on available metrics — a Price/Sales ratio of 0.16x and a net margin of 104% — the company appears to operate in a high-margin, revenue-intensive industry, potentially financial services or a similarly structured sector. With market capitalisation data unavailable, cap tier cannot be formally assigned, though the combination of metrics suggests this warrants cautious treatment as an unverified profile.

Financial Health

**Score: 5/10** The financial picture is genuinely mixed. On the positive side, the net margin of 104% and a gross margin of 1,307% are extraordinarily high figures that, if accurate, suggest exceptional profitability per unit of revenue — though figures of this magnitude may reflect accounting anomalies or one-time items rather than structural strength...

Risk Assessment

- **DATA INTEGRITY:** Gross margin of 1,307% and revenue growth of 1,175% YoY are figures that may reflect accounting distortions, base effects, or corporate restructuring — not necessarily sustainable operational performance. - **EARNINGS DETERIORATION:** Earnings growth of -5,821% YoY stands in stark contradiction to revenue growth, suggesting severe margin compression, extraordinary charges, or a misleading base-period comparison. - **EARNINGS QUALITY:** Free cash flow is unavailable and the company beat analyst estimates in only 1 of 4 recent quarters, raising questions about earnings predictability and reliability. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA), a bearish MACD signal, and price trading below both moving averages indicate sustained negative price momentum. - **ANALYST SENTIMENT:** Only 25% of analysts rate the stock a Buy, with the consensus sitting at Sell — a notable lack of professional conviction in a stock that superficially appears cheap. ---...

Last updated 4 hours ago · Data sourced from FMP & Finnhub · Not financial advice